ARCA biopharma, Inc.

NASDAQ:ABIO

28.8 (USD) • At close August 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 00000000000000015.25146.8613.8880.5450.1952.2926.43324.5915.6046.49.66.20.4
Cost of Revenue 0.1110.1140.0910.0930.0890.0220.0270.024000000000000000-3.124-3-2-1.2-0.4
Gross Profit -0.111-0.114-0.091-0.093-0.089-0.022-0.027-0.024000000015.25146.8613.8880.5450.1952.2926.43324.5918.7289.411.67.40.8
Gross Profit Ratio 000000000000000111111111.21.4691.2081.1942
Reseach & Development Expenses 1.0134.74913.8324.9921.8334.23914.07612.3487.0635.6252.9281.0922.3153.10610.0127.76442.65489.3757.77839.9733.08450.15746.50629.01818.219.29.43.7
General & Administrative Expenses 6.2835.8475.5034.7743.9813.8794.6364.2654.3924.0684.0123.2275.0466.06912.8414.93920.76230.63215.8018.70217.22318.14413.4529.3158.19.54.91.7
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 6.2835.8475.5034.7743.9813.8794.6364.2654.3924.0684.0123.2275.0466.06912.8414.93920.76230.63215.8018.70217.22318.14413.4529.3158.19.54.91.7
Other Expenses 0-0.0050000000000000-1.3422.33624.460.0040.1671.225003.124321.20.4
Operating Expenses 7.29610.59619.3359.7665.8148.11818.71216.61311.4559.6936.944.3197.3619.17522.8541.36163.416144.46273.58348.83951.53268.30159.95841.45729.330.715.55.8
Operating Income -7.296-10.596-19.335-9.766-5.814-8.118-18.712-16.613-11.455-9.693-6.94-4.319-7.361-9.175-36.733-33.251-18.891-140.574-73.038-48.644-49.242-43.935-36.193-22.729-19.9-19.1-8.1-5
Operating Income Ratio 000000000000000-2.18-0.403-36.156-134.015-249.456-21.503-1.662-1.472-1.457-3.109-1.99-1.306-12.5
Total Other Income Expenses Net 1.9570.670.0130.0190.1650.1540.1610.1690.010.0040.001-0.00120.75511.399-6.241-2.336-24.460.269-0.167-1.225-2.067-0.825002.71.70.3
Income Before Tax -5.339-9.926-19.322-9.747-5.649-7.964-18.551-16.444-11.445-9.689-6.939-4.32-5.364-8.42-11.419-29.923-12.301-130.553-71.611-52.489-50.187-76.791-36.76500-16.4-6.4-4.7
Income Before Tax Ratio 000000000000000-1.962-0.262-33.578-131.396-269.174-21.916-2.905-1.49500-1.708-1.032-11.75
Income Tax Expense -0.111-0.67-0.091-0.009-0.167-0.031-0.0610.1880.0140.0070.0050.0020.0050.763-2.2813.813-4.254-10.021-1.4273.8450.9453.11-0.293-0.476-1.4-2.7-1.6-0.2
Net Income -5.339-9.256-19.231-9.738-5.482-7.931-18.49-16.463-11.445-9.689-6.939-4.32-5.364-8.42-9.138-29.923-12.301-130.553-71.611-52.489-50.187-44.978-36.472-22.253-18.5-16.4-6.5-4.8
Net Income Ratio 000000000000000-1.962-0.262-33.578-131.396-269.174-21.916-1.702-1.483-1.426-2.891-1.708-1.048-12
EPS -0.37-0.64-1.38-2.07-4.15-10.31-31.91-32.68-32.76-59.55-101.32-244.8-403.98-748.38-974.1-29,863.27-3,487.67-38,375.37-26,231.14-25,717.3-36,053.88-88,365.42-85,816.47-73,685.43-64,236.11-57,543.86-23,214.29-17,142.86
EPS Diluted -0.37-0.64-1.38-2.07-4.15-10.31-31.91-32.68-32.76-59.55-101.32-244.8-403.98-748.38-974.1-29,863.27-3,487.67-38,375.37-26,231.14-25,717.3-36,053.88-88,365.42-85,816.47-73,685.43-64,236.11-57,543.86-23,214.29-17,142.86
EBITDA -7.296-10.596-19.322-9.738-5.553-7.934-18.545-16.124-11.422-9.674-6.909-4.274-6.757-8.074-22.176-17.584-11.876-112.932-70.639-44.36-42.488-33.539-29.439-19.605-16.9-19.8-8.6-4.9
EBITDA Ratio 000000000000000-1.153-0.253-29.046-129.613-227.487-18.554-1.269-1.197-1.256-2.641-2.063-1.387-12.25